Alembic Pharmaceuticals is currently trading at Rs. 762.90, up by 15.40 points or 2.06% from its previous closing of Rs. 747.50 on the BSE.
The scrip opened at Rs. 740.00 and has touched a high and low of Rs. 766.10 and Rs. 727.95 respectively. So far 26695 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1150.00 on 18-Dec-2020 and a 52 week low of Rs. 720.80 on 23-Aug-2021.
Last one week high and low of the scrip stood at Rs. 820.00 and Rs. 727.95 respectively. The current market cap of the company is Rs. 14996.78 crore.
The promoters holding in the company stood at 69.48%, while Institutions and Non-Institutions held 16.94% and 13.58% respectively.
Alembic Pharmaceuticals has made a strategic investment in RIGlmmune Inc., a biopharmaceutical research company. Alembic has acquired preferred stock in RIGlmmune amounting to a 19.97% post-money stake in the first closing of the series seed round that was completed recently. This investment will help the Company to get into niche segment of new chemical entities.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.
